Stock Information
Maze Therapeutics Inc (MAZE)
Ticker Symbol: MAZE
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,450.60 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.51
Revenue (TTM): $0.34 M
Dividend Yield: N/A
ROE: -34.94%
Latest News
-
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
Tue, Oct 6, 2026 8:05 PM
-
3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight
Mon, Oct 5, 2026 2:55 PM
Key Financials
Financial data not available